These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31674042)

  • 21. Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: implications for clinical practice in hospital and outpatient settings.
    Tannous B; Lee-Lewandrowski E; Sharples C; Brugge W; Bigatello L; Thompson T; Benzer T; Lewandrowski K
    Clin Chim Acta; 2009 Feb; 400(1-2):120-2. PubMed ID: 19000907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New screening method for occult gastrointestinal bleeding: immunologic and guaiac slide tests.
    Stelling HP; Maimon H; Smith RA; Bigley NJ; Mukherjee MD
    J Fam Pract; 1984 Dec; 19(6):757-61. PubMed ID: 6438268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis.
    Lee MW; Pourmorady JS; Laine L
    Am J Gastroenterol; 2020 May; 115(5):662-670. PubMed ID: 31972617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.
    Rabeneck L; Zwaal C; Goodman JH; Mai V; Zamkanei M
    Clin Biochem; 2008 Nov; 41(16-17):1289-305. PubMed ID: 18796300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.
    Hol L; Wilschut JA; van Ballegooijen M; van Vuuren AJ; van der Valk H; Reijerink JC; van der Togt AC; Kuipers EJ; Habbema JD; van Leerdam ME
    Br J Cancer; 2009 Apr; 100(7):1103-10. PubMed ID: 19337257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of chemical tests for fecal occult blood in hospitalized patients.
    Morris DW; Hansell JR; Ostrow JD; Lee CS
    Am J Dig Dis; 1976 Oct; 21(10):845-52. PubMed ID: 1087829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program.
    Sultanian R; Du L; Moysey B; Morse A; Veldhuyzen van Zanten S; Montano-Loza AJ
    J Can Assoc Gastroenterol; 2020 Aug; 3(4):177-184. PubMed ID: 32671327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
    Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
    Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
    Goede SL; Rabeneck L; van Ballegooijen M; Zauber AG; Paszat LF; Hoch JS; Yong JH; Kroep S; Tinmouth J; Lansdorp-Vogelaar I
    PLoS One; 2017; 12(3):e0172864. PubMed ID: 28296927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
    Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.
    Ko CW; Dominitz JA; Nguyen TD
    Am J Med; 2003 Aug; 115(2):111-4. PubMed ID: 12893396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.
    Paszat L; Sutradhar R; Tinmouth J; Baxter N; Rabeneck L
    Can J Gastroenterol Hepatol; 2016; 2016():4768728. PubMed ID: 27446842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis.
    Zhu MM; Xu XT; Nie F; Tong JL; Xiao SD; Ran ZH
    J Dig Dis; 2010 Jun; 11(3):148-60. PubMed ID: 20579218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of fecal occult blood test as a screening test before capsule endoscopy.
    Efthymiou M; Allen PB; Jayasekera C; Taylor PV; Taylor AC
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):690-4. PubMed ID: 21677588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings.
    Elsafi SH; Alqahtani NI; Zakary NY; Al Zahrani EM
    Clin Exp Gastroenterol; 2015; 8():279-84. PubMed ID: 26392783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.
    Greenwald B
    Gastroenterol Nurs; 2005; 28(2):90-6. PubMed ID: 15832108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
    Koïvogui A; Mab GL; Benamouzig R
    Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.